| Serial Number | 77917378 |
| Word Mark | NULLBODY |
| Filing Date | Thursday, January 21, 2010 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, February 2, 2018 |
| Registration Number | 3983268 |
| Registration Date | Tuesday, June 28, 2011 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 15, 2011 |
| Goods and Services | Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and or agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment of cancer, multi enzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti -inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, pharmaceutical preparations for the treatment of insomnia and other sleep related diseases |
| Goods and Services | Contract manufacturing service in the field of antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; contract manufacturing service in the field of host cells; contract extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; providing information in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; technical consultation in the field of manufacturing technology in the field of transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies; providing information in the field of manufacturing technology in the field of host cells; technical consultation in the field of manufacturing technology in the field of host cells; providing technical information in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals; technical consultation in the field of extracting, refining, synthesizing, manufacturing and preparing pharmaceuticals, agricultural chemicals, and chemicals |
| Goods and Services | Development of new products for others in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; providing technical information in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells; technical consultation in the field of development of new products in the field of antibodies, fragments of antibodies, derivatives of antibodies, cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, transfected cells that manufacture antibodies, fragments of antibodies, and derivatives of antibodies, and host cells |
| Pseudo Mark | NULL BODY |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, February 2, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, February 2, 2018 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, February 2, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Kyowa Hakko Kirin Co., Ltd. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Tokyo JP |
| Party Name | Kyowa Hakko Kirin Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Tokyo JP |
| Party Name | Kyowa Hakko Kirin Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Tokyo JP |
| Event Date | Event Description |
| Friday, February 2, 2018 | CANCELLED SEC. 8 (6-YR) |
| Tuesday, June 28, 2016 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Thursday, August 11, 2011 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, August 11, 2011 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, June 28, 2011 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 24, 2011 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| Friday, May 20, 2011 | NOTICE OF ALLOWANCE CANCELLED |
| Tuesday, May 24, 2011 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Friday, May 20, 2011 | TEAS DELETE 1(B) BASIS RECEIVED |
| Tuesday, April 12, 2011 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, February 15, 2011 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 15, 2011 | PUBLISHED FOR OPPOSITION |
| Friday, January 7, 2011 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, January 7, 2011 | ASSIGNED TO LIE |
| Thursday, January 6, 2011 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, January 6, 2011 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, January 6, 2011 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 6, 2011 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 6, 2011 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, January 6, 2011 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, December 20, 2010 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, December 8, 2010 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, December 6, 2010 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, December 1, 2010 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, December 1, 2010 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 1, 2010 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 1, 2010 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, November 10, 2010 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 10, 2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, November 10, 2010 | ASSIGNED TO LIE |
| Friday, October 22, 2010 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, April 26, 2010 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 26, 2010 | NON-FINAL ACTION E-MAILED |
| Monday, April 26, 2010 | NON-FINAL ACTION WRITTEN |
| Monday, April 19, 2010 | ASSIGNED TO EXAMINER |
| Wednesday, January 27, 2010 | NOTICE OF PSEUDO MARK MAILED |
| Tuesday, January 26, 2010 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Monday, January 25, 2010 | NEW APPLICATION ENTERED IN TRAM |